The quest for a coronavirus vaccine has moved from “if” to “when,” with a Quebec City-based company announcing “very promising results” in Phase 1 clinical trials.Medicago’s report comes on the…
This content is for QCT Online members only.
Join Now
Join Now
Already a member? Log in here
‘Promising’ Medicago COVID-19 vaccine moves to Phase 2/3 trials was last modified: November 17th, 2020 by